J. Herod

发表

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

D. Oram, M. Parmar, I. Jacobs, 2016, The Lancet.

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

Matthew Burnell, Steven J Skates, Tim Mould, 2009, Journal of Family Planning and Reproductive Health Care.

Vulvar intraepithelial neoplasia with superficially invasive carcinoma of the vulva

J. Herod, M. Shafi, D. Luesley, 1996, British journal of obstetrics and gynaecology.

Hormone replacement therapy following breast and gynaecological cancer

J. Herod, D. Kolomainen, 2001 .

J. Herod, Kolomainen, 2001 .

Placement of a Malecot catheter to enable embryo transfer after radical trachelectomy.

J. Herod, R. Gazvani, T. Aust, 2005, Fertility and sterility.

Efficacy of Systematic Pelvic Lymphadenectomy in Endometrial Cancer (MRC ASTEC Trial): A Randomized Study

J. Herod, D. Barton, R. Naik, 2009, International Journal of Gynecologic Cancer.

Recruitment to multicentre trials lessons from

Lesley, Leeson, M. Parmar, 2008 .

UKCTOCS: descriptive study Recruitment to multicentre trialslessons from

M. Parmar, I. Jacobs, U. Menon, 2008 .

Adjuvant treatment after hysterectomy for uterine leiomyosarcoma

J. Herod, M. Adishesh, R. Lord, 2015 .

The pathology and management of endocervical glandular neoplasia

J. Herod, A. El-Ghobashy, C. Herrington, 2004, International Journal of Gynecologic Cancer.

Paracentesis in ovarian cancer: a study of the physiology during free drainage of ascites.

J. Herod, Gillian C Smith, S. B. Decruze, 2010, Journal of palliative medicine.

The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2.

J C Reed, D. Kerr, J. Herod, 1995, Oncogene.

The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma.

J. Warwick, D. Kerr, J. Herod, 1996, Cancer research.

Overexpression of cyclins A and B as markers of neoplastic glandular lesions of the cervix.

J. Herod, A. El-Ghobashy, A. Shaaban, 2004, Gynecologic oncology.

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial

H. Kitchener, M. Parmar, G. Jayson, 2015, The Lancet.

Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening

Matthew Burnell, Martin Widschwendter, Tim Mould, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort.

Matthew Burnell, Steven J Skates, Tim Mould, 2011, The Lancet. Oncology.

Infertility after fertility-preserving surgery for cervical carcinoma: the next challenge for reproductive medicine?

J. Herod, R. Gazvani, T. Aust, 2007, Human fertility.

Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: retrospective audit

J. Herod, D. Tincello, R. Kingston, 2002, BMJ : British Medical Journal.

Primary cervical and uterine corpus lymphoma; a case report and literature review.

J. Herod, Michail Kotsyfakis, A. Anagnostopoulos, 2013, International journal of clinical and experimental medicine.

A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix.

J. Herod, C. Poole, J. Dunn, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Recruitment to multicentre trials—lessons from UKCTOCS: descriptive study

M. Parmar, I. Jacobs, U. Menon, 2008, BMJ : British Medical Journal.

Risk of epithelial ovarian cancer in asymptomatic women with ultrasound‐detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS)

D. Oram, I. Jacobs, M. Parmar, 2012, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials

M. Parmar, I. Jacobs, U. Menon, 2011, Trials.

Case Report Primary cervical and uterine corpus lymphoma; a case report and literature review

J. Herod, Michail Kotsyfakis, United King, 2013 .

Perforation with the GyneFix® intrauterine implant: is there a common factor?

J. Herod, J. N. Kirwan, T. Aust, 2003, Journal of Family Planning and Reproductive Health Care.

Premalignant vulval disorders

J. Herod, J. Kirwan, 2002 .

A retrospective clinical audit of cervical smears reported as ‘glandular neoplasia’

J. Herod, L. Turnbull, P. A. Smith, 2004, Cytopathology : official journal of the British Society for Clinical Cytology.

The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

M. Parmar, I. Jacobs, U. Menon, 2017, British Journal of Cancer.

Chemotherapy or upfront surgery for newly diagnosed advanced ovarian cancer: Results from the MRC CHORUS trial.

M. Parmar, H. Kitchener, G. Jayson, 2013 .

The social work role in multi-disciplinary teams

J. Herod, M. Lymbery, Mark Lymbery, 2002 .

Ruptured uterus during middle trimester abortion with gemeprost

J. Herod, M. Shafi, J. Watts, 1994 .

Recruitment to multicentre trials—lessons from UKCTOCS: descriptive study

M. Parmar, U. Menon, A. Ryan, 2008, British medical journal.

Recruitment to multicentre trials—lessons from UKCTOCS: descriptive study

M. Parmar, U. Menon, A. Gentry-Maharaj, 2008, BMJ : British Medical Journal.